HeartLight Ablation in Patients With Paroxysmal Atrial Fibrillation (PAF)

Not Recruiting

Trial ID: NCT01456000

Age - 18 Years-75 Years Condition - Atrial Fibrillation Gender - All Accepting Healthy Volunteers - No

Purpose

The purpose of this study is to demonstrate the safety and effectiveness of the CardioFocus Endoscopic Ablation System with Adaptive Contact (HeartLight) in the treatment of atrial fibrillation by creating electrical isolation of the pulmonary veins.

Official Title

Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) or HEARTLIGHT for the Treatment of Symptomatic Atrial Fibrillation

Eligibility


Inclusion Criteria:

   - 18 to 75 years.

   - paroxysmal atrial fibrillation

   - failure of at least one AAD

   - others

Exclusion Criteria:

   - overall good health as established by multiple criteria

View More
View Less

Intervention(s):

device: EAS-AC (HeartLight)

procedure: Control Arm Ablation

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Gerri O'Riordan
650-725-5597

©2024 Stanford Medicine